| Next 10 |
CHEK News and Press, Check-Cap Ltd.
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the start of another day comes our breakdown of the biggest pre-market stock movers and this time it’s for Thursday! Source: ventdusud / Shutterstock.com Earnings reports, heavy volume, and more have sto...
-
Check-Cap Ltd. (NASDAQ:CHEK) has added ~7% in the pre-market Wednesday after the clinical-stage medical diagnostics company announced the initiation of a U.S. pivotal trial for C-Scan, an investigational screening test to detect colorectal cancer. The two-part open-label trial start...
-
Check-Cap Announces Initiation of the U.S. Pivotal Trial PR Newswire ISFIYA, Israel , May 11, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the...
-
Check-Cap press release (NASDAQ:CHEK): Q4 GAAP EPS of -$0.21 misses by $0.16. Cash and cash equivalents, restricted cash and short-term bank deposits as of December 31, 2021 were $51.9M. For further details see: Check-Cap GAAP EPS of -$0.21 misses by $0.16
-
Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results PR Newswire Company anticipates initiation of the first part of its U.S. pivotal study in April 2022 ISFIYA, Israel , April 7, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "...
-
Check-Cap Ltd. (NASDAQ:CHEK) traded at a new 52-week high today of $19.77. Approximately 301.1 million shares have changed hands today, as compared to an average 30-day volume of 1.7 million shares. Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development ...
-
Check Cap (NASDAQ:CHEK) has slumped ~34% pre-market after the medical diagnostics firm announced a $10M equity offering. The offering comprises 20M of the company's ordinary shares and accompanying warrants to purchase up to an aggregate of 15M of the its ordinary shares. Each ordin...
-
Check-Cap Ltd. Announces $10 Million Registered Direct Offering PR Newswire ISFIYA, Israel , March 1, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancin...
-
Check-Cap (NASDAQ:CHEK) plans to start the U.S. pivotal study for its C-Scan cancer screening test after the FDA approved its amended Investigational Device Exemption (IDE) application, the company announced on Monday. Designed to identify the polyps before they become colorectal cancer, C-Sc...
-
Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan Company anticipates initiation of first part of pivotal study in the March-April 2022 timeframe PR Newswire ISFIYA, Israel , Feb. 7, 2022 /PRNewswire/ -- Check-Cap Ltd. ...
Stock Information
Check-Cap Ltd. Company Name:
CHEK Stock Symbol:
NASDAQ Market:
MENU
CHEK
CHEK Quote
CHEK Short
CHEK News
CHEK Articles
Get CHEK Alerts
News, Short Squeeze, Breakout and More Instantly...
-
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the start of another day comes our breakdown of the biggest pre-market stock movers and this time it’s for Thursday! Source: ventdusud / Shutterstock.com Earnings reports, heavy volume, and more have sto...
-
Check-Cap Announces Initiation of the U.S. Pivotal Trial PR Newswire ISFIYA, Israel , May 11, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the...
-
Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results PR Newswire Company anticipates initiation of the first part of its U.S. pivotal study in April 2022 ISFIYA, Israel , April 7, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "...